English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Maternal drug use causes low birthweight but less is known about longer-term pediatric growth. The purpose of this analysis was to longitudinally measure anthropometric growth among children exposed to drugs in utero. We used data from the National Institute on Drug Abuse (NIDA)-funded Maternal Lifestyle Study (MLS). Mixed effects piecewise regression longitudinally assessed BMI percentile from 2–16 years. Those born low birthweight prenatally exposed to poly tobacco/opioid use had lower pediatric BMI percentiles than those unexposed from 2–16 years. Specific combinations of drug use appear to delay or accelerate growth across childhood at different points for those born low birthweight.

Longitudinal effect of prenatal polydrug use and birthweight status on pediatric growth